Related references
Note: Only part of the references are listed.α-Synuclein and neuronal cell death
Mark R. Cookson
MOLECULAR NEURODEGENERATION (2009)
Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein
He-Jin Lee et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Parkinson's disease
Bobby Thomas et al.
HUMAN MOLECULAR GENETICS (2007)
Structural characterization of the intrinsically unfolded protein β-synuclein, a natural negative regulator of α-synuclein aggregation
Carlos W. Bertoncini et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Small molecule inhibitors of aggregation indicate that amyloid β oligomerization and fibrillization pathways are independent and distinct
Mihaela Necula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Dynamics of α-synuclein aggregation and inhibition of pore-like oligomer development by β-synuclein
Igor F. Tsigelny et al.
FEBS JOURNAL (2007)
Relationships between the sequence of α-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity
Michael J. Volles et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
A century-old debate on protein aggregation and neurodegeneration enters the clinic
Peter T. Lansbury et al.
NATURE (2006)
Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage
Nirit Lev et al.
NEUROSCIENCE LETTERS (2006)
Prediction of aggregation-prone and aggregation-susceptible regions in proteins associated with neurodegenerative diseases
AP Pawar et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Intravesicular localization and exocytosis of α-synuclein and its aggregates
HJ Lee et al.
JOURNAL OF NEUROSCIENCE (2005)
Partial D-amino acid substitution:: Improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptide
R Tugyi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Inhibition of islet amyloid polypeptide fibril formation: A potential role for heteroaromatic interactions
Y Porat et al.
BIOCHEMISTRY (2004)
beta-synuclein-derived peptides with neuroprotective activity - An alternative treatment of neurodegenerative disorders?
M Windisch et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2004)
β-synuclein inhibits formation of α-synuclein protofibrils:: A possible therapeutic strategy against Parkinson's disease
JY Park et al.
BIOCHEMISTRY (2003)
The N-terminal repeat domain of α-synuclein inhibits β-sheet and amyloid fibril formation
JC Kessler et al.
BIOCHEMISTRY (2003)
Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases
F Chiti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Pathogenesis of Parkinson's disease:: Dopamine, vesicles and α-synuclein
J Lotharius et al.
NATURE REVIEWS NEUROSCIENCE (2002)
α-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils
HA Lashuel et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Biophysical properties of the synucleins and their propensities to fibrillate -: Inhibition of α-synuclein assembly by β- and γ-synucleins
VN Uversky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Therapeutic strategies for human amyloid diseases
JC Sacchettini et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
A possible role for pi-stacking in the self-assembly of amyloid fibrils
E Gazit
FASEB JOURNAL (2002)
Learning and memory in Transgenic mice Modeling Alzheimer's disease
KH Ashe
LEARNING & MEMORY (2001)
Targeting small Aβ oligomers:: the solution to an Alzheimer's disease conundrum?
WL Klein et al.
TRENDS IN NEUROSCIENCES (2001)
Parkinson's disease-associated α-sylnuclein is more fibrillogenic than β- and γ-synuclein and cannot cross-seed its homologs
AL Biere et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse α-synuclein
JC Rochet et al.
BIOCHEMISTRY (2000)
Review: History of the amyloid fibril
JD Sipe et al.
JOURNAL OF STRUCTURAL BIOLOGY (2000)
Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
LC Serpell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A Drosophila model of Parkinson's disease
MB Feany et al.
NATURE (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
KA Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
